Showing results (541-550 of 589) with videos related to
Sort By:
Pageof 59
Lung Cancer (Amsterdam, Netherlands)|July 27, 2012
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II ConsortiumNicholas P Campbell, Rangesh Kunnavakkam, Natasha Leighl, et al.Annals of Surgical Oncology|March 5, 2013
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axillaBas B Koolen, Renato A Valdés Olmos, Jelle Wesseling, et al.Plos One|March 21, 2012
Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, IndonesiaMaarten A Wildeman, Renske Fles, Marlinda Adham, et al.Nature Medicine|April 6, 2023
Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trialXiao Tong Teong, Kai Liu, Andrew D Vincent, et al.BMC Cancer|December 31, 2013
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolitesNynke G L Jager, Rutger H T Koornstra, Andrew D Vincent, et al.Pharmacy (Basel, Switzerland)|August 27, 2021
Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in PsychopharmacologyHervé Javelot, Clara Gitahy Falcao Faria, Frederik Vandenberghe, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancerF Rothé, J-F Laes, D Lambrechts, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 19, 2017
Associations of Undiagnosed Obstructive Sleep Apnea and Excessive Daytime Sleepiness With Depression: An Australian Population StudyCarol J Lang, Sarah L Appleton, Andrew Vakulin, et al.Breast Cancer Research and Treatment|December 4, 2012
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancerJorma J de Ronde, Esther H Lips, Lennart Mulder, et al.Breast Cancer Research : BCR|January 29, 2014
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patientsKarin Beelen, Mark Opdam, Tesa M Severson, et al.Pageof 59